UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$850M |
| 2 |
Apple
AAPL
|
+$778M |
| 3 |
Tesla
TSLA
|
+$569M |
| 4 |
iShares MSCI ACWI ETF
ACWI
|
+$351M |
| 5 |
Johnson & Johnson
JNJ
|
+$336M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$372M |
| 2 |
Meta Platforms (Facebook)
META
|
+$237M |
| 3 |
CTXS
Citrix Systems Inc
CTXS
|
+$223M |
| 4 |
iShares US Real Estate ETF
IYR
|
+$217M |
| 5 |
Vertiv
VRT
|
+$144M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.83% |
| 2 | Healthcare | 7.49% |
| 3 | Financials | 7.15% |
| 4 | Consumer Discretionary | 4.92% |
| 5 | Industrials | 4.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4676
PUT
Canadian Pacific Kansas City
CP
$82.6B
| $485K | ﹤0.01% |
+6,500
| New | +$489K |
|
4677
AMERISAFE
AMSF
$504M
| $484K | ﹤0.01% |
9,320
+8,170
| +710% | +$433K |
|
4678
PUT
Green Dot
GDOT
$770M
| $484K | ﹤0.01% |
+30,600
| New | +$564K |
|
|
JMIA
4679
Jumia Technologies
JMIA
$768M
| $484K | ﹤0.01% |
150,633
-63,592
| -30% | -$287K |
|
4680
MicroSectors FANG+ Index -3X Inverse Leveraged ETNs due January 8, 2038
FNGD
$312M
| $483K | ﹤0.01% |
82
-246
| -75% | -$1.52M |
|
4681
JPMorgan Diversified Return Emerging Markets Equity ETF
JPEM
$390M
| $483K | ﹤0.01% |
9,804
-714
| -7% | -$34.2K |
|
4682
Harmony Biosciences
HRMY
$2.24B
| $483K | ﹤0.01% |
8,767
+8,401
| +2,295% | +$462K |
|
|
CMRX
4683
DELISTED
Chimerix, Inc.
CMRX
| $481K | ﹤0.01% |
258,781
-117,292
| -31% | -$229K |
|
4684
Invesco International Corporate Bond ETF
PICB
$361M
| $481K | ﹤0.01% |
22,738
+5,831
| +34% | +$119K |
|
4685
Verra Mobility
VRRM
$731M
| $481K | ﹤0.01% |
34,762
+14,334
| +70% | +$218K |
|
|
NOTE
4686
DELISTED
FiscalNote
NOTE
| $481K | ﹤0.01% |
6,328
-1,172
| -16% | -$79.5K |
|
4687
Amphastar Pharmaceuticals
AMPH
$858M
| $478K | ﹤0.01% |
17,074
+1,624
| +11% | +$47.2K |
|
|
SCS
4688
DELISTED
Steelcase
SCS
| $478K | ﹤0.01% |
67,643
+54,957
| +433% | +$406K |
|
|
CGC
4689
Canopy Growth
CGC
$426M
| $478K | ﹤0.01% |
20,680
+5,131
| +33% | +$158K |
|
4690
Integra LifeSciences
IART
$1.42B
| $477K | ﹤0.01% |
8,510
-14,071
| -62% | -$716K |
|
|
AHRT
4691
AH Realty Trust
AHRT
$506M
| $477K | ﹤0.01% |
41,480
+7,447
| +22% | +$85.8K |
|
4692
TriMas Corp
TRS
$1.39B
| $477K | ﹤0.01% |
17,179
+13,565
| +375% | +$362K |
|
4693
iShares GNMA Bond ETF
GNMA
$433M
| $476K | ﹤0.01% |
10,940
+8,047
| +278% | +$349K |
|
4694
LiveRamp
RAMP
$2.31B
| $476K | ﹤0.01% |
20,290
-823
| -4% | -$16.6K |
|
4695
CALL
Alnylam Pharmaceuticals
ALNY
$30.4B
| $475K | ﹤0.01% |
+2,000
| New | +$427K |
|
4696
Adaptive Biotechnologies
ADPT
$3.89B
| $475K | ﹤0.01% |
62,136
+35,131
| +130% | +$273K |
|
|
ESTE
4697
DELISTED
Earthstone Energy Inc. Class A Common Stock
ESTE
| $475K | ﹤0.01% |
33,346
-5,780
| -15% | -$85.8K |
|
4698
Kennametal
KMT
$2.32B
| $473K | ﹤0.01% |
19,668
+17,156
| +683% | +$425K |
|
4699
MacroGenics
MGNX
$259M
| $473K | ﹤0.01% |
70,498
+2,282
| +3% | +$12.5K |
|
4700
PUT
Acadia Healthcare
ACHC
$2.82B
| $469K | ﹤0.01% |
+5,700
| New | +$470K |
|
Similar funds
UBS Group's Q4 2022 Portfolio in Review
As of Q4 2022, UBS Group held 12,049 positions worth $268B, up 17% from $228B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS Group deployed $21.8B of net new capital in Q4 2022, opening 1,180 new positions and adding to 5,214 existing holdings. Its largest new stake was Avantis US Small Cap Value ETF: 210,571 shares worth $15.7M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 11% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Salesforce, an estimated $372M trimmed.
- UBS Group's largest Q4 2022 buy was Avantis US Small Cap Value ETF: 210,571 shares worth $15.7M.
- UBS Group added most to Microsoft in Q4 2022, an estimated $850M increase.
- UBS Group's biggest Q4 2022 reduction was Salesforce, cutting an estimated $372M.
- UBS Group fully exited Citrix Systems Inc in Q4 2022, selling an estimated $223M.
- UBS Group's ten largest holdings make up 13% of its $268B portfolio in Q4 2022.
- UBS Group opened 1,180 new positions and closed 1,371 in Q4 2022.
- UBS Group's portfolio value rose 17% quarter-over-quarter to $268B.
Based on UBS Group's 13F filing for Q4 2022, filed 8 Feb 2023.